These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27266076)

  • 21. Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.
    Geuss LR; Suggs LJ
    Biotechnol Prog; 2013; 29(5):1089-96. PubMed ID: 23956196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outstanding problems in retinal detachment. Management of vitreous and retinal detachment in diabetic retinopathy.
    Blach RK
    Trans Ophthalmol Soc U K (1962); 1975 Apr; 95(1):158-64. PubMed ID: 1064198
    [No Abstract]   [Full Text] [Related]  

  • 24. Stem cells, progenitors & regenerative medicine: A retrospection.
    Bhartiya D
    Indian J Med Res; 2015 Feb; 141(2):154-61. PubMed ID: 25900949
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future challenges for patient-specific induced pluripotent stem cells in cardiovascular medicine.
    Sun X; Tan G; Liew R
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):943-5. PubMed ID: 23030280
    [No Abstract]   [Full Text] [Related]  

  • 27. "Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells.
    Zhang G; Zhang Y
    Stem Cell Res Ther; 2015 Dec; 6():255. PubMed ID: 26687081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.
    Kimbrel EA; Lanza R
    Regen Med; 2015; 10(2):99-102. PubMed ID: 25835474
    [No Abstract]   [Full Text] [Related]  

  • 29. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of perfluorocarbon liquids in diabetic vitrectomy.
    Itoh R; Ikeda T; Sawa H; Kolzumi K; Yasuhara T; Yamamoto Y; Kusada E
    Ophthalmic Surg Lasers; 1999; 30(8):672-5. PubMed ID: 10507571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming and transdifferentiation shift the landscape of regenerative medicine.
    Guo J; Wang H; Hu X
    DNA Cell Biol; 2013 Oct; 32(10):565-72. PubMed ID: 23930590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic manipulation and studying of differentiation properties of rat induced pluripotent stem cells].
    Liskovykh MA; Chuĭkin IA; Ranjan A; Popova E; Tolkunova EN; Chechik LL; Malinin AIu; Morozova AV; Mosienko V; Bader M; alenina N; Tomilin AN
    Tsitologiia; 2011; 53(12):946-51. PubMed ID: 22359953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cutting-edge of medicine: progress and prospects: induced pluripotent stem cell research for neurological diseases].
    Ito D; Suzuki N
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3230-6. PubMed ID: 24605575
    [No Abstract]   [Full Text] [Related]  

  • 34. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to mend a broken heart: adult and induced pluripotent stem cell therapy for heart repair and regeneration.
    Wegener M; Bader A; Giri S
    Drug Discov Today; 2015 Jun; 20(6):667-85. PubMed ID: 25720353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cells create a therapeutic niche.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
    [No Abstract]   [Full Text] [Related]  

  • 40. MicroRNA-induced pluripotent stem cells.
    Tan GC; Dibb NJ
    Malays J Pathol; 2012 Dec; 34(2):167-8; author reply 169. PubMed ID: 23424782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.